5 July 2022 - The July 2022 issue of the New Zealand Pharmaceutical Schedule is now available and in effect.

There are a few new/revised listings of note this month:

• Tenofovir disoproxil fumarate - new indication (generic medicine)
• Emtricitabine with tenofovir disoproxil fumarate - new indication (generic medicine)
• Gemtuzumab ozogamicin - new medicine
• Anti-retrovirals - new indication (includes generic medicines)
• Multiple sclerosis treatments – restriction change
• Azacitidine - new indication (includes generic medicine)
• Palivizumab - new indication
• Trastuzumab emtansine - new indication

Read New Zealand Pharmaceutical Schedule update